An implantable hemodynamic monitor safely monitored hemodynamic changes in patients with severe pulmonary arterial hypertension.
Inhaled epoprostenol delivered via high-flow nasal cannula increased oxygenation among patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction.
Patients with chronic thromboembolic pulmonary hypertension had increased plasma concentrations of osteopontin, which may be involved in fibrotic remodeling.
Patients with idiopathic pulmonary artery hypertension undergoing a lung transplant in which extracorporeal life support is needed experienced poorer outcomes compared with patients with other diagnoses.
A new meta-analysis evaluated and compared the efficacy and safety of balloon pulmonary angioplasty with that of riociguat therapy in patients with inoperable chronic thromboembolic pulmonary hypertension.
Transcatheter aortic valve implantation is associated with lower rates of cardiac complications than surgical aortic valve replacement in people with pulmonary hypertension.
The novel echocardiographic pulmonary to left atrial global strain ratio distinguishes pre-capillary from post-capillary pulmonary hypertension.
Patients with heart failure, severe pulmonary hypertension, and a preserved ejection fraction of ≥50% had a worse prognosis when compared with other patients with heart failure and severe pulmonary hypertension.